Drug giant Glaxo has succeeded in extending the term for a patent for a drug that treats chronic obstructive pulmonary disease and asthma, with a delegate rejecting arguments from law firm Banki Haddock Fiora that the application was incorrectly based on a patent that was no longer valid because of amendments.
ANZ shareholder drops case over climate change risk management
Albanese government to pump $200 million into a revamped Administration Appeals Tribunal
Moves to restore public confidence in the government reviews process are underway after the federal Parliament passed new legislation replacing the “damaged” Administrative Appeals Tribunal, which has been criticised for failing to stop the Robodebt scheme, with a new Administrative Review Tribunal.
What’s unjust about them? Full Court appears open to contingency fees for class action lawyers
IAG hit with class action over ‘misleading’ loyalty discounts
Lawyers for cartel immunity seekers could soon be shut out of ACCC interviews
Don’t ask AI questions you don’t already know the answers to, law firm says
Noumi, ASIC fight ruling that privilege over PwC report waived during probe
Continuous disclosure case law may apply in Forge insider trading case, judge says
A judge has left open the question of whether a line of authority relating to the materiality of information under the continuous disclosure regime could be relevant to a stoush between collapsed engineering firm Forge Group and Clough Group, saying the decisions may apply to cases alleging breaches of the insider trading provisions of the Corporations Act.